Citadel Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.8K | Sell |
27,300
-5,900
| -18% | -$7.18K | ﹤0.01% | 12545 |
|
|
2025
Q4 | $32.6K | Buy |
33,200
+15,700
| +90% | +$18.9K | ﹤0.01% | 12200 |
|
|
2025
Q3 | $22.1K | Buy |
17,500
+4,100
| +31% | +$4.42K | ﹤0.01% | 12476 |
|
|
2025
Q2 | $15K | Buy |
13,400
+8,000
| +148% | +$9.3K | ﹤0.01% | 12158 |
|
|
2025
Q1 | $4.27K | Sell |
5,400
-10,500
| -66% | -$12.9K | ﹤0.01% | 13904 |
|
|
2024
Q4 | $26.2K | Buy |
15,900
+6,900
| +77% | +$17.4K | ﹤0.01% | 12988 |
|
|
2024
Q3 | $31.5K | Sell |
9,000
-5,000
| -36% | -$19.5K | ﹤0.01% | 12388 |
|
|
2024
Q2 | $45.9K | Buy |
14,000
+4,400
| +46% | +$19.3K | ﹤0.01% | 11857 |
|
|
2024
Q1 | $70.5K | Sell |
9,600
-1,200
| -11% | -$7.43K | ﹤0.01% | 11814 |
|
|
2023
Q4 | $40.4K | Buy |
10,800
+2,000
| +23% | +$4.72K | ﹤0.01% | 12002 |
|
|
2023
Q3 | $18.7K | Sell |
8,800
-13,600
| -61% | -$45.1K | ﹤0.01% | 12682 |
|
|
2023
Q2 | $107K | Sell |
22,400
-3,400
| -13% | -$18.8K | ﹤0.01% | 10841 |
|
|
2023
Q1 | $147K | Sell |
25,800
-4,600
| -15% | -$27.8K | ﹤0.01% | 10669 |
|
|
2022
Q4 | $307K | Buy |
30,400
+17,600
| +138% | +$331K | ﹤0.01% | 9268 |
|
|
2022
Q3 | $287K | Sell |
12,800
-100
| -0.8% | -$2.89K | ﹤0.01% | 9675 |
|
|
2022
Q2 | $320K | Sell |
12,900
-8,300
| -39% | -$229K | ﹤0.01% | 9662 |
|
|
2022
Q1 | $822K | Buy |
21,200
+2,100
| +11% | +$81.3K | ﹤0.01% | 8158 |
|
|
2021
Q4 | $1.12M | Sell |
19,100
-1,700
| -8% | -$96.4K | ﹤0.01% | 7684 |
|
|
2021
Q3 | $1.23M | Buy |
20,800
+3,300
| +19% | +$259K | ﹤0.01% | 7598 |
|
|
2021
Q2 | $1.52M | Sell |
17,500
-11,200
| -39% | -$903K | ﹤0.01% | 7288 |
|
|
2021
Q1 | $2.37M | Buy |
28,700
+800
| +3% | +$76.7K | ﹤0.01% | 6007 |
|
|
2020
Q4 | $2.54M | Sell |
27,900
-1,900
| -6% | -$118K | ﹤0.01% | 4862 |
|
|
2020
Q3 | $1.19M | Buy |
29,800
+5,200
| +21% | +$182K | ﹤0.01% | 5713 |
|
|
2020
Q2 | $844K | Buy |
24,600
+6,000
| +32% | +$179K | ﹤0.01% | 6145 |
|
|
2020
Q1 | $413K | Sell |
18,600
-12,100
| -39% | -$306K | ﹤0.01% | 6769 |
|
|
2019
Q4 | $601K | Buy |
+30,700
| New | +$488K | ﹤0.01% | 6511 |
|
|
2019
Q2 | – | Sell |
-19,400
| Closed | -$341K | – | 9358 |
|
|
2019
Q1 | $341K | Buy |
19,400
+300
| +2% | +$4.74K | ﹤0.01% | 7421 |
|
|
2018
Q4 | $245K | Buy |
+19,100
| New | +$266K | ﹤0.01% | 7580 |
|
Other funds holding FATE
RG
VCM
VPM
JJ
